Japan Implements Stricter Regulations on Over-the-Counter Medicine Sales

The Japanese government has introduced tighter controls on the sale of over-the-counter (OTC) medicines in response to increasing concerns about misuse and health risks associated with these products. Recent reports indicate a significant rise in the non-medical use of easily accessible medications, particularly among younger populations.

Pharmacies and drugstores across Japan are now required to adhere to new regulations aimed at curbing the improper consumption of OTC drugs. Under these measures, pharmacists and pharmacy staff must verify the age and identity of customers using official documentation, such as health insurance cards. Additionally, they are mandated to check whether individuals have made comparable purchases at other locations, reducing the likelihood of repeated or excessive buying.

The regulatory changes come amid growing evidence of young people, especially women, attempting to use cold remedies and similar medications for recreational purposes. Authorities have documented a surge in cases where individuals have been hospitalized due to overdoses or acute poisoning resulting from the misuse of OTC drugs. The trend has become more pronounced since the onset of the COVID-19 pandemic, with a marked increase in the number of incidents involving common pharmacy and drugstore medicines.

The Ministry of Health, Labour and Welfare has issued warnings about the serious dangers posed by the unsupervised use of these medications. Health officials highlight that misuse can result in severe health consequences, including loss of consciousness, cardiac arrest, addiction, and in some cases, death. The ministry's guidance underscores the addictive potential of certain over-the-counter drugs when taken inappropriately or in excessive quantities.

In line with the revised Pharmaceutical and Medical Device Act, sales of specific medicines--including some cough syrups, cold remedies, fever reducers, and allergy medications--are now restricted for individuals under the age of 18. Customers in this age group are only permitted to purchase a single small package of such medications, generally sufficient for five to seven days of treatment.

Pharmacists and staff are further obligated to inform customers about the risks of improper or excessive use of these products. They must also ensure that certain medications, particularly those at higher risk of misuse, are stored securely and kept out of direct consumer reach, thereby preventing unauthorized or impulsive access.

The strengthened oversight measures are intended to address the dual challenges of increasing drug misuse and the associated public health risks. Authorities emphasize the importance of responsible dispensing practices and heightened vigilance among pharmacy personnel. These efforts form part of Japan's broader strategy to protect vulnerable groups, such as adolescents and young adults, from the dangers linked to unregulated access to potentially harmful medications.

While the new policies place additional responsibilities on pharmacists and retailers, officials believe that these steps are crucial for safeguarding public health and reducing the prevalence of OTC drug abuse. The government continues to monitor the situation closely and has indicated that it may introduce further measures if necessary to ensure the safe and appropriate use of non-prescription medicines across the country.